이 에피소드에 관해
In this episode of Let’s Talk Patient Blood Management, we dig into one of the boldest platelet stewardship moves in recent years: cutting prophylactic platelet doses in halffor cancer patients without increasing bleeding.
Lead author Christine Cahill and Dr. Majed Refaai explain why platelets are overused, always in short supply, and far from a benign therapy. They walk us through how arbitrarythresholds like ‘hemoglobin 10’ and ‘platelets 50’ became ingrained, and what happened when their team at the University of Rochester implemented half‑dose plateletsin the real world, and why many ‘just in case’ transfusions may never have been needed in the first place.
We cover:
- Why platelets are prothrombotic and proinflammatory
- How 'just in case' transfusions can lead to refractoriness and no compatible units available
- Blood Inventory pressures of a level 1 trauma center, and triaging platelets to those who truly need them
- Real-world outcomes when platelet volumes are cut in half
If you have ever ordered one unit just to feel better about a lab value, then this conversation will challenge how you think about prophylactic transfusion, safety, dose, and indication.
Read Article Here: https://pubmed.ncbi.nlm.nih.gov/42087249/
Visit Let's Talk PBM Website:
Music Created with SUNO
